AutomatingIntegrity.DefiningCompliance.

EU GMP-regulated pharmaceutical manufacturers must produce a continuous stream of quality documents: supplier audits, product quality reviews, regulatory submissions, and more. Each requires days of manual preparation by senior QA professionals.

Existing solutions store and track documents but do not generate them. The work remains entirely manual, consuming expensive expert capacity that should be focused on judgment-intensive decisions.

QA²I combines Quality Assurance and Artificial Intelligence, with the "²" symbolizing QA amplified by AI.

We started QA²I with a single belief: that the most important documents in pharmaceutical manufacturing, the ones that prove product safety and process control to regulators, should not be the ones most prone to human error and delay.

Our ambition isn't to remove humans from compliance. It is to give the experts the most capable assistants. The AI handles what's repetitive: reading, cross-referencing, drafting. The expert handles what matters: verifying, judging, deciding. AI that reasons across data, prepares documents with domain fluency, and defers to human judgment at every gate. Less time assembling, more time deciding.

QA²I uses AI agents to automate preparation of compliant, traceable pharmaceutical quality documents. Specialized agents handle document ingestion, cross-document consistency checks, regulatory criteria matching, and structured output generation within a validated pipeline.

Every output traces back to source documents, satisfying EU GMP Annex 11 and ALCOA+ requirements. Human experts review and approve all outputs. The result is audit-ready documentation produced in a fraction of the time and cost of manual preparation.